Amanote Research
Register
Sign In
PSY31 Economic Evaluation of Eletriptan 40mg for Migraine Therapy in Korea
Value in Health
- United Kingdom
doi 10.1016/j.jval.2012.03.565
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
June 1, 2012
Authors
H.J. Kim
J.J. Oh
H.J. Park
S.K. Ko
Publisher
Elsevier BV
Related search
Novel Biologics Versus Conventional Preventive Therapies in Migraine: A Framework for Economic Evaluation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Eletriptan Provides Consistent Migraine Relief: Results of a Within-Patient Multiple-Dose Study
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Eletriptan in the Management of Acute Migraine: An Update on the Evidence for Efficacy, Safety, and Consistent Response
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health Insurance
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Socio–economic Costs of Migraine
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Pnd132 - Economic Burden of Migraine in Brazil: Results From My Migraine Voice Survey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Korea Institute for International Economic Policy (KIEP)
Trends in Mathematics
Mathematics
Repetitive Intravenous Dihydroergotamine as Therapy for Intractable Migraine
Neurology
Neurology
The Ex-Post Economic Evaluation of Water Resource Management in South Korea: Meta-Regression Analysis
